论文部分内容阅读
受政府规章的限制,到现在为止,美国在生物技术方面的输出还很少。上个月在华盛顿举行的工业生物技术协会第四次年度会议上,Genex 公司的 Ruth Greenstein 指出这种状况也许会改变的。生物技术公司认为,控制情报和技术从本国流出是难以做到的,并认为这样会阻碍生物技术的发展。然而美国国防部(DOD)却担心,生物技术可能会给苏联和东欧国家带来军事优势。DOD 已将一些生物技术项目列入它的“保密册”中,这可能就是初步
Due to the restrictions of government regulations, the output of the United States in biotechnology has so far been very small. At the fourth annual meeting of the Industrial Biotechnology Association in Washington last month, Ruth Greenstein of Genex stated that this situation may change. Biotechnology companies believe that it is difficult to control the flow of intelligence and technology out of the country and that this will hinder the development of biotechnology. However, the US Department of Defense (DOD) is concerned that biotechnology may bring military advantage to the Soviet Union and Eastern European countries. DOD has included some biotechnology projects in its “secret book”, which may be preliminary